Doctorglasses Chain Income Statement

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022
Operating Revenue	1,387	1,360	1,190	1,161	951.51	881.1
Other Revenue	-	-	12.68	14.63	10.72	6.37
Revenue	1,387	1,360	1,203	1,176	962.24	887.47
Revenue Growth (YoY)	12.52%	13.10%	2.29%	22.20%	8.43%	35.22%
Cost of Revenue	547.91	536.41	470.37	442.18	373.9	313.84
Gross Profit	839.53	823.97	732.44	733.69	588.34	573.63
Selling, General & Admin	638.7	633.66	592.02	564.92	498.69	454.23
Research & Development	1.95	2.01	3.08	4.67	-	-
Other Operating Expenses	3.88	3.33	4.15	4.99	1.91	2.64
Operating Expenses	644.15	639.01	599.58	575.31	501.06	457.35
Operating Income	195.38	184.96	132.86	158.38	87.28	116.28
Interest Expense	-	-	-8.61	-7.69	-9.02	-9.09
Interest & Investment Income	7.52	8.03	16.3	15.24	9.43	9.4
Currency Exchange Gain (Loss)	-	-	-0.77	0.52	0.31	0.33
Other Non Operating Income (Expenses)	-11.05	-10.04	-4.61	-3.77	-3.44	-3.5
EBT Excluding Unusual Items	191.85	182.96	135.16	162.68	84.57	113.42
Impairment of Goodwill	-	-	-12.14	-5.3	-	-
Gain (Loss) on Sale of Investments	28.03	24.39	2.21	4.58	-0.83	-0.39
Gain (Loss) on Sale of Assets	0.83	0.52	2.35	0.88	2.26	0.59
Asset Writedown	-15.95	-15.88	-4.04	-0.14	-0.1	-0.1
Other Unusual Items	-	-	5.57	1.44	6.94	7.71
Pretax Income	204.76	191.99	129.12	164.13	92.84	121.24
Income Tax Expense	40.75	38.3	27.8	32.37	18.4	26.74
Earnings From Continuing Operations	164.01	153.69	101.32	131.76	74.44	94.5
Minority Interest in Earnings	-5.68	-5.08	2.31	-3.69	1.37	0.28
Net Income	158.33	148.61	103.63	128.06	75.81	94.78
Net Income to Common	158.33	148.61	103.63	128.06	75.81	94.78
Net Income Growth	45.57%	43.40%	-19.08%	68.93%	-20.02%	37.02%
Shares Outstanding (Basic)	226	229	228	225	219	220
Shares Outstanding (Diluted)	229	229	228	225	224	224
Shares Change (YoY)	1.81%	0.12%	1.50%	0.46%	-0.03%	2.14%
EPS (Basic)	0.70	0.65	0.45	0.57	0.35	0.43
EPS (Diluted)	0.69	0.65	0.45	0.57	0.34	0.42
EPS Growth	42.98%	43.23%	-20.27%	68.15%	-19.99%	34.15%
Free Cash Flow	269.92	276.29	249.53	259.34	182.13	170.83
Free Cash Flow Per Share	1.18	1.21	1.09	1.15	0.81	0.76
Dividend Per Share	-	-	0.208	0.462	0.231	0.385
Dividend Growth	-	-	-55.00%	99.96%	-39.99%	42.87%
Gross Margin	60.51%	60.57%	60.89%	62.40%	61.14%	64.64%
Operating Margin	14.08%	13.60%	11.05%	13.47%	9.07%	13.10%
Profit Margin	11.41%	10.92%	8.62%	10.89%	7.88%	10.68%
Free Cash Flow Margin	19.45%	20.31%	20.75%	22.05%	18.93%	19.25%
EBITDA	207.84	196.47	140.55	172.3	97.85	125.52
EBITDA Margin	14.98%	14.44%	11.68%	14.65%	10.17%	14.14%
D&A For EBITDA	12.46	11.51	7.69	13.92	10.57	9.23
EBIT	195.38	184.96	132.86	158.38	87.28	116.28
EBIT Margin	14.08%	13.60%	11.05%	13.47%	9.07%	13.10%
Effective Tax Rate	19.90%	19.95%	21.53%	19.72%	19.82%	22.05%
Revenue as Reported	27.05	-	1,203	1,176	962.24	887.47
Advertising Expenses	-	-	7.69	6.98	4.23	2.72

Source: S&P Global Market Intelligence. Standard template. Financial Sources.